Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging

Andrew Wilber, Joel L. Frandsen, Kirk J. Wangensteen, Stephen C Ekker, Xin Wang, R. Scott McIvor

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Nonviral gene therapy approaches face the challenge of achieving stable gene expression in target organs and tissues. We used fluorescence microscopy and in vivo imaging after rapid, high-volume delivery of plasmid DNA (pDNA) encoding DsRed and luciferase as products of the same mRNA to detect localized gene expression in liver. Plasmids encoding the luciferase gene transcriptionally regulated by cellular and viral promoters were injected under similar conditions to test for potency and stability of gene expression in the liver of adult mice. Animals were imaged at 3, 6, 12, 24, and 48 hr and followed up at 1- to 2-week intervals over 2 months to identify maximum and persistent luciferase expression after injection of equimolar amounts of each plasmid. Emitted light representing luciferase expression was detected as early as 3 hr after pDNA infusion, reaching maximum levels at 12 hr for promoters containing viral sequences and at 24 hr for elements from human genes. Viral elements displayed 10- to 20-fold higher peak levels of expression but also yielded the most dramatic decline in expression over 8 weeks. In contrast, only a moderate decrease was observed for the cellular ubiquitin C promoter during that same period of time. Both promoter-deleted and phosphoglycerate kinase (PGK)-containing plasmids failed to maintain luciferase expression at levels above the limit of detection. These results demonstrate fine temporal analyses of reporter gene activity using promoters of various strength, suggesting an effective and reproducible method for studying gene therapy vectors in vivo.

Original languageEnglish (US)
Pages (from-to)1325-1332
Number of pages8
JournalHuman Gene Therapy
Volume16
Issue number11
DOIs
StatePublished - Nov 2005
Externally publishedYes

Fingerprint

Luciferases
Plasmids
Gene Expression
DNA
Genetic Therapy
Ubiquitin C
Phosphoglycerate Kinase
Liver
Reporter Genes
Fluorescence Microscopy
Genes
Limit of Detection
Light
Messenger RNA
Injections

ASJC Scopus subject areas

  • Genetics

Cite this

Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging. / Wilber, Andrew; Frandsen, Joel L.; Wangensteen, Kirk J.; Ekker, Stephen C; Wang, Xin; McIvor, R. Scott.

In: Human Gene Therapy, Vol. 16, No. 11, 11.2005, p. 1325-1332.

Research output: Contribution to journalArticle

Wilber, Andrew ; Frandsen, Joel L. ; Wangensteen, Kirk J. ; Ekker, Stephen C ; Wang, Xin ; McIvor, R. Scott. / Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging. In: Human Gene Therapy. 2005 ; Vol. 16, No. 11. pp. 1325-1332.
@article{9a2548aa05b14ce9b5c03c46993b60a7,
title = "Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging",
abstract = "Nonviral gene therapy approaches face the challenge of achieving stable gene expression in target organs and tissues. We used fluorescence microscopy and in vivo imaging after rapid, high-volume delivery of plasmid DNA (pDNA) encoding DsRed and luciferase as products of the same mRNA to detect localized gene expression in liver. Plasmids encoding the luciferase gene transcriptionally regulated by cellular and viral promoters were injected under similar conditions to test for potency and stability of gene expression in the liver of adult mice. Animals were imaged at 3, 6, 12, 24, and 48 hr and followed up at 1- to 2-week intervals over 2 months to identify maximum and persistent luciferase expression after injection of equimolar amounts of each plasmid. Emitted light representing luciferase expression was detected as early as 3 hr after pDNA infusion, reaching maximum levels at 12 hr for promoters containing viral sequences and at 24 hr for elements from human genes. Viral elements displayed 10- to 20-fold higher peak levels of expression but also yielded the most dramatic decline in expression over 8 weeks. In contrast, only a moderate decrease was observed for the cellular ubiquitin C promoter during that same period of time. Both promoter-deleted and phosphoglycerate kinase (PGK)-containing plasmids failed to maintain luciferase expression at levels above the limit of detection. These results demonstrate fine temporal analyses of reporter gene activity using promoters of various strength, suggesting an effective and reproducible method for studying gene therapy vectors in vivo.",
author = "Andrew Wilber and Frandsen, {Joel L.} and Wangensteen, {Kirk J.} and Ekker, {Stephen C} and Xin Wang and McIvor, {R. Scott}",
year = "2005",
month = "11",
doi = "10.1089/hum.2005.16.1325",
language = "English (US)",
volume = "16",
pages = "1325--1332",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging

AU - Wilber, Andrew

AU - Frandsen, Joel L.

AU - Wangensteen, Kirk J.

AU - Ekker, Stephen C

AU - Wang, Xin

AU - McIvor, R. Scott

PY - 2005/11

Y1 - 2005/11

N2 - Nonviral gene therapy approaches face the challenge of achieving stable gene expression in target organs and tissues. We used fluorescence microscopy and in vivo imaging after rapid, high-volume delivery of plasmid DNA (pDNA) encoding DsRed and luciferase as products of the same mRNA to detect localized gene expression in liver. Plasmids encoding the luciferase gene transcriptionally regulated by cellular and viral promoters were injected under similar conditions to test for potency and stability of gene expression in the liver of adult mice. Animals were imaged at 3, 6, 12, 24, and 48 hr and followed up at 1- to 2-week intervals over 2 months to identify maximum and persistent luciferase expression after injection of equimolar amounts of each plasmid. Emitted light representing luciferase expression was detected as early as 3 hr after pDNA infusion, reaching maximum levels at 12 hr for promoters containing viral sequences and at 24 hr for elements from human genes. Viral elements displayed 10- to 20-fold higher peak levels of expression but also yielded the most dramatic decline in expression over 8 weeks. In contrast, only a moderate decrease was observed for the cellular ubiquitin C promoter during that same period of time. Both promoter-deleted and phosphoglycerate kinase (PGK)-containing plasmids failed to maintain luciferase expression at levels above the limit of detection. These results demonstrate fine temporal analyses of reporter gene activity using promoters of various strength, suggesting an effective and reproducible method for studying gene therapy vectors in vivo.

AB - Nonviral gene therapy approaches face the challenge of achieving stable gene expression in target organs and tissues. We used fluorescence microscopy and in vivo imaging after rapid, high-volume delivery of plasmid DNA (pDNA) encoding DsRed and luciferase as products of the same mRNA to detect localized gene expression in liver. Plasmids encoding the luciferase gene transcriptionally regulated by cellular and viral promoters were injected under similar conditions to test for potency and stability of gene expression in the liver of adult mice. Animals were imaged at 3, 6, 12, 24, and 48 hr and followed up at 1- to 2-week intervals over 2 months to identify maximum and persistent luciferase expression after injection of equimolar amounts of each plasmid. Emitted light representing luciferase expression was detected as early as 3 hr after pDNA infusion, reaching maximum levels at 12 hr for promoters containing viral sequences and at 24 hr for elements from human genes. Viral elements displayed 10- to 20-fold higher peak levels of expression but also yielded the most dramatic decline in expression over 8 weeks. In contrast, only a moderate decrease was observed for the cellular ubiquitin C promoter during that same period of time. Both promoter-deleted and phosphoglycerate kinase (PGK)-containing plasmids failed to maintain luciferase expression at levels above the limit of detection. These results demonstrate fine temporal analyses of reporter gene activity using promoters of various strength, suggesting an effective and reproducible method for studying gene therapy vectors in vivo.

UR - http://www.scopus.com/inward/record.url?scp=27744574725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744574725&partnerID=8YFLogxK

U2 - 10.1089/hum.2005.16.1325

DO - 10.1089/hum.2005.16.1325

M3 - Article

C2 - 16259566

AN - SCOPUS:27744574725

VL - 16

SP - 1325

EP - 1332

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 11

ER -